Reaction Details |
| Report a problem with these data |
Target | 5-hydroxytryptamine receptor 2A |
---|
Ligand | BDBM35254 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1853388 (CHEMBL4354012) |
---|
Ki | 5.6±n/a nM |
---|
Citation | Hogendorf, AS; Hogendorf, A; Kurczab, R; Kalinowska-T?u?cik, J; Popik, P; Nikiforuk, A; Krawczyk, M; Sata?a, G; Lenda, T; Knutelska, J; Bugno, R; Staro?, J; Pietru?, W; Mat?oka, M; Dubiel, K; Moszczy?ski-P?tkowski, R; Pieczykolan, J; Wieczorek, M; Pilarski, B; Zajdel, P; Bojarski, AJ 2-Aminoimidazole-based antagonists of the 5-HT Eur J Med Chem179:1-15 (2019) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
5-hydroxytryptamine receptor 2A |
---|
Name: | 5-hydroxytryptamine receptor 2A |
Synonyms: | 5-HT-2 | 5-HT-2A | 5-HT2A | 5-hydroxytryptamine receptor 2A (5-HT-2A) | 5-hydroxytryptamine receptor 2A (5HT-2A) | 5-hydroxytryptamine receptor 2A (5HT2A) | 5HT2A_HUMAN | HTR2 | HTR2A | Serotonin receptor 2A |
Type: | undefined |
Mol. Mass.: | 52607.65 |
Organism: | Homo sapiens (Human) |
Description: | P28223 |
Residue: | 471 |
Sequence: | MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGC
LSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIAD
MLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNP
IHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSF
VSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIH
REPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGA
LLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYK
SSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV
|
|
|
BDBM35254 |
---|
n/a |
---|
Name | BDBM35254 |
Synonyms: | 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine | CHEMBL715 | Olansek | US8802672, Olanzapine | Zyprexa | olanzapine |
Type | Small organic molecule |
Emp. Form. | C17H20N4S |
Mol. Mass. | 312.432 |
SMILES | CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12 |t:8| |
Structure |
|